Alexis Shaw has extensive work experience in the field of compliance. Alexis started their career at Ernst & Young in 2002 as a Manager in Fraud Investigations & Dispute Services, where they worked until 2011. Following that, they joined Boston Scientific as a Global Compliance Investigations Manager from 2011 to 2014. Shaw then worked at Endo Pharmaceuticals as a Deputy Compliance Officer from 2014 to 2016, and later as a Compliance Officer from 2016 to 2018. Currently, they hold the position of Executive Director, Compliance at Paratek Pharmaceuticals since March 2021, after serving as Senior Director, Compliance from 2018 to 2021.
Alexis Shaw obtained a Bachelor of Science (BS) degree in Accounting from Bucknell University, which they attended from 1998 to 2002. Alexis also holds a certification as a Certified Fraud Examiner from the Association of Certified Fraud Examiners (ACFE), for which the exact month and year of attainment are not provided.
January 1, 2024 - present
March, 2021
July, 2018